<< Back

Research highlight updates from the eight EURION projects

The 4th Annual Meeting of the EURION Cluster was held on 30–31 January 2023 in Amsterdam, the Netherlands to present and discuss the latest advances in research by the EURION Cluster towards improving the identification of endocrine disruptors.

The aim of the EURION Annual Meeting was to facilitate cross-project collaboration on topics of common interest and maximise synergies between the projects. Furthermore, the meeting informs and engages with stakeholders and the EURION International Advisory Panel for Regulatory Affairs (IAP).

Two sessions on the morning of 30 January were open to everyone interested to attend virtually via Zoom. The meeting which took place at Vrije Universiteit Amsterdam in the Netherlands was attended about 140 delegates including Cluster members, IAP members and EURION observers. The open morning sessions provided attendees with the highlights of the activities and results from each of the eight EURION Cluster projects. The projects are developing new testing and screening methods to identify endocrine disrupting chemicals (EDCs). EDCs are chemicals which mimic natural hormones, that can produce adverse effects by disrupting the body’s endocrine (hormone) system. This hormone disruption can affect brain development, fertility, thyroid function, metabolism and therefore lead to medical disorders such as obesity, diabetes, breast cancer, non-alcoholic fatty liver disease (NAFLD), irregular menstrual cycles and endometriosis, to name but a few.

To learn more about these innovative projects and hear their latest research activities, please check out the Project Highlights from each of the Coordinators presented at the EURION Cluster Annual Meeting in January 2023 as well as reading the 2023 Meeting Report.